Memorial Sloan Kettering Commack (Consent and Follow-Up)
Memorial Sloan Kettering Commack (Consent and Follow-Up)
Commack, New York, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, adenoma, breast cancer, breast disorder, breast neoplasm, epithelial neoplasm, lung cancer, lung disorder, lung neoplasm, mesothelial neoplasm, mesothelioma, neoplasm, respiratory system disorder, respiratory tract neoplasm, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-22 | NCT02414269 |